With antibiotic-resistant “superbugs” infecting 2 million people per year, and a dearth of new medications in the pipeline to treat them, CU Boulder researchers are taking a novel approach to addressing the looming public health crisis.
More than 5 million people suffer from fibromyalgia, a syndrome characterized by chronic muscle discomfort, sleep problems, pain hypersensitivity and sometimes mood disorders.